Atlas Trials

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients

Clinical trial NCT06169072 · RECRUITING

Trial details

NCT number
NCT06169072
Sponsor
Vastra Gotaland Region
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerSentinel Lymph Node
Start date
2023-01-01
Primary completion
2024-07-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.